Pfizer Inc. and Gilead Sciences Inc. communications with the US Trade Representative show the companies' efforts to quash measures in Malaysia deemed harmful to the pharmaceutical industry, according to a series of communications obtained under the Freedom of Information Act by the nongovernmental organization Knowledge Ecology International (KEI).
KEI released the emails between the USTR and both companies in Nov. 28 and 29 blog postings. Pfizer's communications...





